So you didn't even look for any actual efficacy studies done in the last 2 years. 2 years, 100s of thousands of hospitalizations and a ton of deaths but no details. Just BS numbers that I've already seen. No breakdown of comorbidities, no breakdown by age, nothing. Again, lots of pretty words with 0 substance. Your evidence gathering is useless.
When you're talking PREVENTION, there is no efficacy study. If someone gets in a motorcycle accident with a helmet on, do you think they then smash the person's head to see if they would have died without a helmet on?
You said it yourself that they don't know how sick a person WOULD have gotten without the vaccine, but the FACT is that as the percentage of people vaccinated RISES, the percentage of those being hospitalized who are unvaccinated has stayed almost the same. If the vaccine had no efficacy in reducing the severity of the symptoms, then the percentages would roughly match the population: You would see about 85% of people being hospitalized and being fully vaccinated.
That's how statistics work.
So, looking at the numbers: What is your theory of why the vast majority of adult hospitalizations remain unvaccinated people, while a solid majority of adult people (85%) are vaccinated? Why aren't the vaccinated people being hospitalized?
What is the common thread aside from vaccination that crosses ethnic, ***, financial, political, geographic, etc. boundaries for all of these people?
Again, it's pretty much impossible for it to be coincidence. There must be a cause, and you must know that cause if you know it's not the vaccination. What is it?
Efficacy studies info:
https://www.cdc.gov/vaccines/covid-19/effectiveness-research/protocols.html
A study funded and led by the Centers for Disease Control and Prevention (CDC) will evaluate how well COVID-19 vaccines prevent laboratory-confirmed, symptomatic COVID-19 in healthcare workers in the “real world,” outside of a clinical trial.
www.cdc.gov
COVID-19 vaccines protect against COVID-19. Get safety info and more.
www.cdc.gov
.+
Efficacy study on 43,548 participants:
https://www.nejm.org/doi/full/10.1056/nejmoa2034577
CONCLUSIONS -A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.
www.who.int
All COVID-19 vaccines
approved by WHO for
emergency use listing have been through randomized clinical trials to test their quality, safety and efficacy.
To be approved, vaccines are required to have a high efficacy rate of 50% or above.
Studies and Statistics, not politics or political talking points.